🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Vasiliki Pelekanou

Bayer (United States)

ORCID: 0000-0002-8431-1927

Also affiliated with Bayer (Germany)

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer.

54 citations

Sarat Chandarlapaty, Hannah M. Linden, Gary A. Ulaner, Alice Gosselin, Sylvaine Cartot‐Cotton +12 more

11 citations

Yalai Bai, Vasiliki Pelekanou, Zeina Nahleh, Saba Shafi, Sneha Burela +12 more

0 citations

Michal Marczyk, Tao Qing, Tess A. O’Meara, Vesal Yaghoobi, Vasiliki Pelekanou +9 more

22 citations

Tao Qing, Tess A. O’Meara, Vesal Yagahoobi, Vasiliki Pelekanou, Yalai Bai +11 more